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Abstract
Objective Hereditary myopathy with early respiratory failure (HMERF) is caused by titin A-band mutations in exon 344 
and considered quite rare. Respiratory insufficiency is an early symptom. A collection of families and patients with muscle 
disease suggestive of HMERF was clinically and genetically studied.
Methods Altogether 12 new families with 19 affected patients and diverse nationalities were studied. Most of the patients 
were investigated using targeted next-generation sequencing; Sanger sequencing was applied in some of the patients and 
available family members. Histological data and muscle MRI findings were evaluated.
Results Three families had several family members studied while the rest were single patients. Most patients had distal and 
proximal muscle weakness together with respiratory insufficiency. Five heterozygous TTN A-band mutations were identi-
fied of which two were novel. Also with the novel mutations the muscle pathology and imaging findings were compatible 
with the previous reports of HMERF.
Conclusions Our collection of 12 new families expands mutational spectrum with two new mutations identified. HMERF is 
not that rare and can be found worldwide, but maybe underdiagnosed. Diagnostic process seems to be complex as this study 
shows with mostly single patients without clear dominant family history.
Keywords Hereditary myopathy · Respiratory failure · Titin · Titinopathy, mutations
Introduction
Hereditary myopathy with early respiratory failure (HMERF, 
OMIM #603689) is characterized by proximal and/or dis-
tal muscle weakness, and early and severe diaphragmatic 
insufficiency [1–5]. In HMERF, respiratory failure can be 
a presenting symptom in an ambulant adult patient, which 
is not a common feature in other genetic myopathies [5–7]. 
Typical MRI pattern has been reported with fatty degenera-
tion of semitendinosus and obturator muscles and anterolat-
eral compartment of lower legs early in the disease course 
[4, 5, 8, 9, 10]. Muscle histopathology shows cytoplasmic 
bodies usually in subsarcolemmal necklace-like formation, 
occasional rimmed vacuoles and myofibrillar disorganiza-
tion responsible for Z-disc alterations [11].
Titin gene mutations in exon 344 encoding the fibronec-
tin-3 (FN3) domain in the A-band region of titin are associ-
ated with HMERF [4, 5]. The reported mutations mainly 
show an autosomal dominant inheritance pattern, and are 
usually private mutations except for the most frequently 
identified mutation in HMERF patients, c.95134T>C 
p.C31712R, found in more than 20 families in Europe and 
Asia (Table 1) [11–14].
We describe here clinical features, pulmonary function 
tests, histopathological and muscle MRI findings of 19 
HMERF patients from 12 families and diverse ethnic ori-
gins. Five heterozygous TTN A-band mutations were identi-
fied of which two are previously unreported. * Johanna Palmio 
 johanna.palmio@uta.fi
Extended author information available on the last page of the article
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Methods
Patients
The patients belonged to 12 unrelated families (Fig. 1): 
one Filipino/Caucasian (A), one Afghan (B), two Italian 
(C, D), one Spanish (E) patient, one Russian family (F), 
two Portuguese patients (G, H), two French families (I, 
J), one Argentinian (K), one Iranian (L) patient. Family I 
was from the East of France, with two sisters and her Ger-
man cousin affected, while family J was from the South of 
France with two members affected. In the Russian family F 
father and daughter were examined and similarly affected. 
Table 1  Dominant mutations in TTN A-band-exon 344 with clinical findings
PEG percutaneous endoscopic gastrostomy tube feeding, LL lower limbs, UL upper limbs
a In the present study
b Asymptomatic, found on pulmonary function tests
Mutation Nationality No. of 
families 
(patients)
Distribution of 
common muscle 
weakness
Respiratory 
involvement
Other features (no. 
of patients)
References
c.95126C>A 
p.P31709H
Filipino-Caucasian 1 (1) Proximal and distal 
lower limb weak-
ness
1/1 – a
c.95126C>G 
p.P31709R
French 1 (3) Proximal, axial 2/3 – [9]
c.95134T>C 
p.C31712R
British, Swedish, 
Spain/Canada, 
Finnish, Italian, 
Argentinian, Japa-
nese, Chinese
Afghana,  Russiana
33 (96) Proximal, axial and/
or distal myopa-
thy neck flexion, 
ankle dorsiflexion, 
trunk, pelvic 
muscles
69/96 Calf hypertrophy 
(12), finger 
flexion/extension, 
scapular winging 
(6), contractures 
(3), rigid spine/
kyphoscoliosis 
(5), dysphagia 
needing PEG (1), 
head drop (1), 
myalgia, cramps 
(1)
[4, 5, 9, 11, 13, 14, 
15]a
c.95135G>A 
p.C31712Y
Japanese 1 (1) Proximal LL 1/1b – [11]
c.95185T>C 
p.W31729R
German 1 (2) Proximal and distal, 
neck flexion
2/2 Mild facial muscle 
weakness
[9]
c.95186G>T 
p.W31729L
Japanese 1 (20) Ankle dorsiflexion, 
finger extension
7 (not all examined) Dysphagia and 
dysarthria
[10]
c.95187G>C 
p.W31729C
British, Portuguese 4 (4) Distal weakness 4/4 Mild kyphosis (1), 
scapular winging 
(1)
[9, 16]a
c.95346_95354del 
p.R31783_
V31785del
Japanese 1 (1) Distal LL, UL 
weakness
1/1b Myalgia [11]
c.95351C>T 
p.A31784V
French, Argentinian 3 (6) Axial, proximal 
and distal, neck 
flexors, ankle 
dorsiflexion
6/6 Scapular winging 
(2), dysphonia 
(2), calf hypertro-
phy (1)
a
c.95358C>G 
p.N31786K
Brazilian,  Iraniana 1 (1) Proximal UL, LL, 
ankle dorsiflexion
0/1 Scapular winging [15]a
c.95371G>C 
p.G31791R
Japanese 1 (1) Fatigability 1/1 – [11]
c.95372G>A 
p.G31791D
North American, 
Japanese
2 (6) Proximal LL, distal 
LL, neck muscles, 
UL
2/5 + 1/1b Calf hypertrophy 
(4), head drop
[11, 14]
c.95372G>T 
p.G31791V
Japanese 1 (1) Distal LL 1/1b – [11]
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There were no other family members diagnosed with spe-
cific muscle disease in the rest of the families, although, 
some patients had relatives with a history of muscle weak-
ness and/or respiratory problems (Fig. 1/Table 2). Those 
family members were already deceased or otherwise not 
available for this study.
All patients had been clinically examined by the treating 
neurologist, and data on nerve conduction studies and nee-
dle electromyography (EMG), creatine kinase (CK) levels in 
serum and muscle MRI or CT of the lower limbs were also col-
lected. Spirometry test results were available in nine patients. 
An echocardiogram was performed in six patients. The diag-
nosis of HMERF was based on clinical symptoms of respira-
tory insufficiency with muscle weakness and the presence of 
cytoplasmic bodies in muscle biopsy, and/or on a typical pat-
tern of muscle involvement on muscle imaging as described 
previously, i.e., obturator externus, semitendinosus and ante-
rolateral muscles in the distal leg [4, 5, 8, 9, 11].
Muscle samples from the patients were snap frozen, and 
8–10 µm sections were cut and examined using standard his-
tochemical stainings. Samples were also immunostained for 
different myogenic antigens including myosin heavy chain 
isoforms (fetal, neonatal, slow and fast MyHC, MHC class I).
Genetic studies
Genomic DNA was extracted from blood by standard methods. 
Direct Sanger sequencing of the titin exon 344 was performed 
at Emory Genetics Laboratory (http://genet icsla b.emory .edu/) 
in patient B and Tampere Neuromuscular Research Center, 
Finland in patient G. Targeted next-generation sequencing 
(NGS) was performed as previously described [17] in patients 
A, C, D, and H–L. Version 2 of the MYOcap gene panel was 
used that is targeted to the exons of 236 genes including all 
known genes for muscular dystrophy or myopathy at the time. 
In Patient E, an NGS panel targeted to the exons of 119 genes 
known to cause muscular dystrophy or myopathy was per-
formed at the genetic service of Hospital de la Santa Creu i 
Sant Pau, Barcelona, Spain. Targeted sequencing was ordered 
for the proband of Family F from a commercial laboratory 
(Genomed Ltd., Moscow, the list of targeted genes: http://price 
.genom ed.ru/?testi d=826).
TTN variants are described according to the coding DNA 
reference sequence (NG_011618.3 or LRG_391), covering 
transcript variant-IC (NM_001267550.1).
Results
Molecular genetic findings
Novel mutations
A novel A-band mutation c.95126C>A p.P31709H was 
identified in the proband of family A (III-3). The proband’s 
mother and two brothers were similarly affected with res-
piratory insufficiency and muscle weakness but already 
deceased before the study. Her affected half-sister needed 
mechanical ventilation at age 40.
Two French families I and J, as well as one Argen-
tinian patient K were identified with a novel mutation 
c.95351C>T p.A31784V. In family I three affected 
patients were studied. The proband’s affected father (I-1) 
in family J was already deceased and not available for the 
study. However, the son (III-1) was genetically studied as 
he has mild rigid spine although no muscle involvement. 
He did not carry the titin mutation. The proband (II-5) and 
her sister (II-6) also had joint contractures and rigid spine 
that have probably another genetic background.
The previously unknown variants are not listed in 
gnomAD (v2.1), but they are listed in ClinVar as vari-
ants of uncertain significance (ClinVar ID is 283245 for 
c.95126C>A p.P31709H and 497143 for c.95351C>T 
p.A31784V). Moreover, the variant p.P31709H is also 
reported in dbSNP (rs869320739).
Common mutation
Single patients B–E were found to harbor the most fre-
quently identified TTN A-band mutation, c.95134T>C 
p.C31712R [11, 12]. No other family members of these 
patients were available for genetic studies. In addition, the 
proband of family F with several affected members carried 
the same mutation.
Re‑occurring mutations
Patients G and H were identified with c.95187G>C 
p.W31729C previously reported in two single patients [9, 
16]. In patient L the mutation c.95358C>G p.N31786K, 
which has also been found in one British patient, was identi-
fied [15]. DNA samples were available in five healthy family 
members of patient L (mother, four siblings), but none of 
them carried the mutation. The patient and family members 
were also haplotyped, and the mutation was found to be de 
novo in the patient as the same haplotype but not the muta-
tion was identified in healthy family members.
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Table 2  Clinical and genetic data of HMERF patients
TTN A-band-exon 344 c.95126C>A, p.P31709H (novel mutation)
Filipino–Caucasian patient A
Patient Sex/age Age at onset First symptoms Muscle weakness find-
ings at examination
Respiratory symptoms CK/IU/L Biopsy
A: III-3 F/57 31 Proximal and distal 
lower limb weakness
Neck flexors, hip flex-
ors, ankle dorsiflex-
ors, abductor digiti 
minimi
FVC 43%, NIV Normal RV, myofibrillar aggre-
gates
TTN A-band-exon 344 c.95134T>C, p.C31712R (common mutation)
Afghan patient B
B: II-1 F/30 22 Difficulty climbing 
stairs
Bilateral left > right 
calf hypertrophy
Proximal and distal 
LL and UL, left 
worse than right
Waddling and step-
page gait
FVC 30%, nocturnal 
NIV
1.5 × UNL CBs
Italian patient C
C: II-1 M/58 40 Distal weakness toe-
walking
Prox UL, prox and 
dist LL
Yes 3 × UNL Necrotic fibers, fibrosis
Italian patient D
D: II-1 M/56 47 Myalgia, steppage gait Severe neck flexors, 
severe distal UL and 
LL, mild-to-mod-
erate proximal LL, 
mild proximal UL
Mild 2–3 × UNL CBs, RV
Spanish patient E
E: II-1 F/59 50 Distal weakness, 
respiratory failure
Proximal and distal 
weakness, finger 
extension
FVC 30%, NIV Normal Myopathy
Russian family F
F: I-2 F/78a 58 Distal weakness Steppage gait, mild 
proximal LL and 
finger extension
N/A N/A N/A
F: II-1 M/41a 38 Distal weakness Mild tibialis anterior N/A N/A N/A
F: II-3 M/70a 47 Steppage gait Severe distal LL 
(tibialis anterior), 
mild UL (finger 
extension)
N/A N/A N/A
F:III-2 M/59 30 Ankle dorsiflexion 
weakness
Severe distal LL 
(tibialis anterior 
1/5), asymmetric 
UL (finger extension 
2/5, 3/5), mild neck 
flexors and proximal 
LL
FVC 49% 1.5 × UNL N/A
F:IV-1 F/30 30 N/A Tibialis anterior (4/5), 
finger extension 
(4/5)
N/A N/A N/A
TTN A-band-exon 344 c.95187G>C p.W31729C (re-occurring mutation)
Portuguese patient G
G: II-1 M/71 55 Steppage gait Distal LL, mild 
kyphosis, scapular 
winging
Severe, invasive ven-
tilation
Normal CBs
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Clinical findings
Detailed clinical data are presented in Table 2. The mean 
age at symptom onset was 42 years (range 22–58 years). 
The main presenting symptoms were related to lower limb 
proximal or distal weakness in all patients, and to respiratory 
failure at onset in only two patients.
Clinical characteristics of patient A with the novel TTN 
mutation c.95126C>A p.P31709H
A 52-year-old female presented with slowly progres-
sive proximo-distal myopathy starting at age 31 years. 
She had respiratory insufficiency and a need for a non-
invasive ventilation (NIV). Muscle biopsy at age 45 years 
Table 2  (continued)
TTN A-band-exon 344 c.95126C>A, p.P31709H (novel mutation)
Filipino–Caucasian patient A
Patient Sex/age Age at onset First symptoms Muscle weakness find-
ings at examination
Respiratory symptoms CK/IU/L Biopsy
Portuguese patient H
H: II-1 M/62 55 Left foot drop Severe distal LL, mild 
proximal LL and 
UL (4)
VC 49% nocturnal 
NIV
N/A Myopathy
TTN A-band-exon 344 c.95351C>T p.A31784V (novel mutation)
French family I
I:III-1 F/70 55 Dyspnea Pelvic girdle, neck 
flexors, ankle dorsi-
flexion, dysphonia
FVC 30%, nocturnal 
NIV
1.5 × UNL N/A
I:III-5 F/73 24 Pelvic girdle weakness Hip flexion, neck 
flexors abdominal 
muscles, scapular 
winging, ankle 
dorsiflexion, finger 
extensors
FVC 29%, nocturnal 
NIV
N Myofibrillar aggregates
I:III-6 F/67 54 Respiratory failure Hip flexion, neck flex-
ors, trunk muscles, 
dysphonia
FVC 42%, nocturnal 
NIV
N N/A
French family J
J: I-1 M/50a N/A N/A Distal LL Yes N/A CBs
J: II-5 F/58a 44 Distal LL weakness Proximal and distal 
LL, proximal UL, 
axial weakness, 
scapular winging
Yes, FVC 70% 1.5 × UNL CBs
Argentinian patient K
K: II-1 M/54 40 Dyspnea Deltoid (4/5), iliop-
soas and quadriceps 
(4/5), tibialis 
anterior (4−/5, 4/5), 
toe extension (4−/5, 
4/5), unable to walk 
on heels, steppage 
gait, calf hypertro-
phy
FVC 45%, NIV 2.5 × UNL Normal
TTN A-band-exon 344 c.95358C>G p.N31786K (re-occurring mutation)
Iranian patient L
L: II-7 M/42a 26 Difficulty climbing 
stairs
Generalized mus-
cle weakness and 
atrophy
Invasive ventilator 2 × UNL CBs
CBs cytoplasmic bodies, CK creatine kinase, F female, FEV1 forced expiratory volume in one second, FVC forced vital capacity, LL lower 
limbs, M male, MRC Medical Research Council Scale, N/A not available, NIV non-invasive ventilation support, RV rimmed vacuoles, UL upper 
limbs, UNL upper normal limit, VC vital capacity, WCB wheelchair bound
a Age at death
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showed rimmed vacuoles and subtle lesions compatible 
with myofibrillar aggregations (Fig. 2a). No cytoplasmic 
bodies were observed. Muscle imaging could not be per-
formed due to patient’s claustrophobia.
Clinical characteristics of families I–K with the novel 
c.95351C>T p.A31784V mutation
All three patients in family I were followed up for severe 
respiratory failure which progressed slowly since ado-
lescence. One of the patients had been diagnosed with 
asymptomatic restrictive reduced respiratory capacity 
after a systematic screening by the school doctor at the 
age of 12. However, respiratory symptoms, i.e., dyspnea 
did not become apparent before the age of 50 years in 
the patient, which resulted in the need for non-invasive 
nocturnal ventilation. Further, patient II-3 had died at the 
age of 51 years due to respiratory failure after general 
anesthesia and was diagnosed with pulmonary embolism 
at that time. Muscle weakness in the family was pre-
dominant at the pelvic girdle, i.e., hip flexion, but also 
neck flexors and trunk muscles were weak. Ankle dorsi-
flexion and finger extension strength was less severely 
affected. One patient presented with more severe weak-
ness including limitation of arm abduction. She needed 
bilateral help for walking. There was no calf hypertrophy 
or facial weakness, but dysphonia was noted in patients 
III-1 and III-6. They all had kyphoscoliosis since ado-
lescence. Two patients underwent echocardiography with 
normal results. Myofibrillar aggregates were present in 
the muscle biopsy.
The proband (II-5) and her father in Family J showed 
onset of symptoms in the distal lower limbs. Respiratory 
insufficiency was also present in both patients. In addition 
to rigid spine, mandibular and ankle contractures, there 
were axial weakness and scapular winging in the proband 
and she needed a stick for walking. Muscle biopsies in 
both showed cytoplasmic bodies compatible with HMERF 
findings.
Patient K is a 54-year-old male with severe respira-
tory insufficiency, proximal weakness, and no family 
history. At the age of 40 the first respiratory symptoms 
and decreased vital capacity (58%) were noted. Muscle 
symptoms appeared after a few years with proximal upper 
and lower limb weakness. He was also unable to walk on 
heels. Respiratory insufficiency progressed to the vital 
capacity of 45% at age 54 years. EMG was myopathic and 
serum CK level was elevated, but no abnormal findings 
were observed in the muscle biopsy (vastus lateralis at age 
45 years). Cardiac examination including echocardiogram 
was also normal. His mother suffered from dyspnea and 
died suddenly in her sleep at age 70 years.
Patients B–F with the common TTN mutation c.95134T>C 
p.C31712R
The presenting symptoms of the patients were distal lower 
leg weakness usually starting with ankle dorsiflexion weak-
ness and respiratory insufficiency. The age of onset varied 
from 20 to 50 years of age. Muscle weakness slowly pro-
gressed to encompass both upper and lower limb muscles 
proximally and distally. Neck flexor and finger extensor 
weakness were common findings. Respiratory symptoms 
ranged from asymptomatic or mild to severe with a need 
for NIV. CK levels were normal or mildly elevated. Mus-
cle biopsy findings were available from four families and 
revealed cytoplasmic bodies and/or unspecific myopathic/
dystrophic changes (Fig. 2b, c).
In retrospect, family history of these patients was positive 
although none of the relatives had been diagnosed with a 
specific muscle disease. Patient B had a 41-year-old brother 
who had similar symptoms since age 32 and used NIV 24 h 
a day. The mother of patient D who had died at the age of 
67 years due to heart attack, had gait difficulties since aged 
40 followed by respiratory insufficiency, while patient E had 
a sister who had muscle weakness and died because of sud-
den death around 50 years of age. In addition to the proband 
and his daughter in Family F, the proband’s father, paternal 
uncle and grandfather had similar symptoms.
Clinical characteristics of patients G, H, and L 
with re‑occurring TTN mutations
Patient G, a 71-year-old male patient presented with distal 
weakness in the lower limbs starting at the age of 55. He 
presented steppage gait, mild kyphoscoliosis and scapular 
winging. He also had severe respiratory involvement (since 
the age of 68) and needed continuous mechanical ventila-
tion. No signs of cardiomyopathy were revealed by echocar-
diogram. Muscle biopsy showed cytoplasmic bodies. He had 
no clear family history although his father, who died at age 
68 years, had severe muscle weakness, and the father’s sister 
was wheelchair-bound without a known cause.
Patient H is a 62-year-old male whose symptoms began 
at age 55 with foot drop, first on the left, then on the right 
side. He had indications of nocturnal hypoxemia, and res-
piratory evaluations showed reduced VC (sitting 48.9%, 
prone 32.3%) necessitating nocturnal NIV. In addition, mild 
proximal weakness in the upper and lower limbs was noted. 
EMG was myopathic, more severe in the anterior leg mus-
cles. Muscle histology revealed only unspecific myopathic 
changes. The proband had ten brothers of which seven were 
already deceased. Several siblings had gait disturbances 
and some cognitive deterioration but were not available for 
evaluation. The father died at 74 years due to cardiac disease 
and had similar steppage gait but no cognitive impairment.
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Patient L is a 40-year-old male with difficulty in climb-
ing stairs starting aged 26 and no family history. On the 
first examination, proximal muscle weakness in addition 
to steppage gait, calf hypertrophy, and macroglossia were 
present. The weakness was prominent in the shoulder and 
pelvic girdle, finger extensors and rhomboid muscles; facial 
muscles were spared. Respiratory failure developed at the 
age of 30, and at the last examination at age 40 he was bed-
ridden and in need of mechanical ventilation. Echocardiog-
raphy revealed a mildly decreased ejection fraction of 50% 
and mild dilated cardiomyopathy. Cytoplasmic bodies were 
present in his muscle biopsy. The patient died at age 42 as a 
result of respiratory failure.
Muscle imaging
Muscle MRI was performed in ten patients and CT in two 
patients. The most typical finding was fatty degenerative 
changes in semitendinosus and anterolateral muscles of the 
distal lower leg. In addition, at the pelvic level iliopsoas and 
gluteal muscles were affected and at the thigh level quadri-
ceps and gracilis in some of the patients (Fig. 2d–i).
Discussion
Our study on 12 HMERF families shows that the disease 
is not that rare as previously understood and can be found 
worldwide. Together with two novel mutations there are 
more than ten different TTN A-band mutations identified 
leading to typical muscle imaging and histology findings [4, 
5, 11]. Although the mutations reported here are dominant 
many of our patients were single cases rendering the diag-
nosis of a dominant disease challenging.
Muscle weakness in HMERF together with early res-
piratory failure usually involves proximal, distal and trunk 
muscles as the disease progresses. In contrast to most mus-
cular dystrophies the majority of reported HMERF patients 
either had respiratory insufficiency among the presenting 
symptoms or developed failure later during the disease 
course (Table 1). In our study, the mean age of onset of 
respiratory symptoms was 50.3 years (range 30–68 years). 
Three patterns of presenting symptoms can be delineated: 
(1) distal myopathy especially with ankle dorsiflexion 
weakness; (2) pelvic girdle weakness, or (3) respiratory 
insufficiency as a first sign, with the distal presentation 
being most common in our patients (9/19). Despite vari-
able distribution of muscle symptoms, most frequently 
reported affected muscles were neck flexors, finger exten-
sors, ankle dorsiflexors and proximal lower limb muscle 
weakness (Table 1), which are affected also in many of our 
patients [4, 5, 9]. Less frequently reported features such as 
kyphosis, scapular winging, dysphonia or calf hypertrophy 
[18] were rarely present. Coexisting cardiac symptoms, 
i.e., arrhythmias were found in HMERF patients with the 
common c.95134T>C p.C31712R mutation [19]. Only one 
of our patients had signs of mild dilated cardiomyopathy 
(patient L), and cardiac abnormalities occurred very rarely 
also in the previous reports [4, 5, 9, 18].
The hallmarks of the disease, i.e., cytoplasmic bodies in 
muscle biopsy and typical distribution of muscle involve-
ment on imaging, i.e., semitendinosus and anterolateral 
muscles in the distal leg, were frequent findings also with 
the novel mutations. Cytoplasmic bodies, rimmed vacuoles 
and/or myofibrillar aggregates were seen in eight out of 
12 patients studied. Thus typical diagnostic changes were 
not detected in all; however, immunohistochemical stain-
ings, e.g., myotilin, desmin or p62, to improve detection 
of cytoplasmic bodies or myofibrillar aggregates [15] were 
not consistently used in the patients with consistent diag-
nosis. Further, diagnostic findings can be missed in routine 
examinations as cytoplasmic bodies and rimmed vacuoles 
can be present only in rare fibers, which apparently is one 
reason for difficulties to reach a correct diagnosis.
Several dominant mutations in titin A-band have been 
identified in HMERF patents, c.95134T>C p.C31712R 
being the most frequent. The common mutation was 
now diagnosed in patients from the Middle East, South 
America and Russia. This shows that it is not restricted 
to Europe, one haplotype or founder mechanism as previ-
ously thought [15, 20]. We expand the mutational spec-
trum with two novel mutations identified in four families 
resulting in typical generalized muscle weakness and res-
piratory symptoms. In addition to the common mutation, 
the other reported mutations have been identified in single 
patients [11, 12]; two of them now found in our patients.
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Fig. 2  Histological and muscle imaging findings. Patient a haema-
toxylin and eosin staining shows atrophic fibers and rimmed vacuolar 
pathology. b There are numerous mostly subsarcolemmal cytoplasmic 
bodies (CBs) present in the biopsy from patient L with Gomori tri-
chrome staining but CBs can be present in only occasional fibers as 
seen in figure c (patient G). d Muscle MRI from Family I (III-4) with 
the novel mutation shows typical fatty degenerative changes in obtu-
ratorius, semitendinosus and anterior lower leg muscles. The same 
but more severe and diffuse involvement is present in her sister (III-5) 
(G). The mildest form of involvement is demonstrated in E (patient E) 
and more advanced fatty degeneration in F (patient B) and H (fam-
ily F III-2). CT images in figure I (patient K) show the most typical 
changes in HMERF marked with arrows
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